BMS’s repotrectinib to have FoundationOne genomic sequencing companion diagnostic
Pharmaceutical Technology
APRIL 12, 2023
FoundationOne CDx is a sequencing-based in vitro diagnostic device that can identify alterations in 324 genes from tumour samples. Individuals that develop lung cancer with no smoking history are genetically distinct from those who develop the cancer with a smoking history.
Let's personalize your content